Symbols / ALUR $0.74 +12.12% Allurion Technologies Inc.
ALUR Chart
Stock Fundamentals
|
|
|
|
|
|
About
Allurion Technologies Inc. focuses on developing a weight loss platform for overweight people in Spain, France, Turkey, and internationally. Its Allurion Program platform offers the Allurion Smart Capsule, a swallowable and procedure-less intragastric balloon for weight loss, and access to the Allurion Virtual Care Suite, a digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program. The company is headquartered in Natick, Massachusetts.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-02-24 | up | Chardan Capital | Neutral → Buy | $3 |
| 2025-11-20 | main | Chardan Capital | Neutral → Neutral | $3 |
| 2025-03-27 | main | Chardan Capital | Neutral → Neutral | $3 |
| 2025-03-21 | reit | Roth MKM | Buy → Buy | $16 |
| 2025-03-21 | main | Chardan Capital | Neutral → Neutral | $3 |
| 2024-11-14 | down | Chardan Capital | Buy → Neutral | — |
| 2024-10-02 | init | TD Cowen | — → Buy | $2 |
| 2024-09-06 | init | Roth MKM | — → Buy | $2 |
| 2024-08-22 | main | Chardan Capital | Buy → Buy | $3 |
| 2024-05-15 | main | Chardan Capital | Buy → Buy | $5 |
| 2024-04-04 | init | Chardan Capital | — → Buy | $5 |
| 2024-02-09 | init | Jefferies | — → Buy | $5 |
- Are Medical Stocks Lagging Allurion Technologies, Inc. (ALUR) This Year? - Yahoo Finance Fri, 27 Feb 2026 08
- $ALUR stock is up 48% today. Here's what we see in our data. - Quiver Quantitative Mon, 23 Feb 2026 08
- FDA-approved weight loss firm fights to stay on NYSE after warning - Stock Titan Mon, 02 Mar 2026 08
- What's Going On With Allurion Stock On Wednesday? - Allurion Technologies (OTC:ALUR) - Benzinga Wed, 25 Feb 2026 08
- Allurion stock surges 40% on U.S. FDA approval - Investing.com Mon, 23 Feb 2026 08
- Allurion Technologies Received Notice of Delisting - TradingView hu, 12 Mar 2026 07
- Market Movers | Winners: GMGI, TPET, BATL | Losers: AARD, ALUR, PULM - Trefis ue, 03 Mar 2026 08
- Allurion Advances Plan to Regain Listing Compliance - Business Wire hu, 12 Mar 2026 07
- As some quit GLP-1 drugs, Allurion starts treating U.S. patients - Stock Titan Mon, 20 Apr 2026 07
- Allurion stock soars after FDA milestones and debt exchange announcement - Investing.com ue, 11 Nov 2025 08
- Allurion Announces Exercise of Warrants for $3.0 Million in Gross Proceeds - Yahoo Finance ue, 24 Feb 2026 08
- Weight-loss firm targets 20M ex-GLP-1 users as U.S. launch begins - Stock Titan Wed, 11 Mar 2026 07
- $ALUR stock is down 16% today. Here's what we see in our data. - Quiver Quantitative ue, 11 Nov 2025 08
- A swallowable balloon that helps you eat less just won FDA approval - Stock Titan Mon, 23 Feb 2026 08
- Allurion Technologies (OTCID: ALUR) appeals NYSE delisting and leans on new FDA approval - Stock Titan hu, 12 Mar 2026 07
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
15.23
-52.57%
|
32.11
-39.94%
|
53.47
-16.73%
|
64.21
|
| Operating Revenue |
|
15.23
-52.57%
|
32.11
-39.94%
|
53.47
-16.73%
|
64.21
|
| Cost Of Revenue |
|
5.66
-46.65%
|
10.61
-11.39%
|
11.97
-11.23%
|
13.48
|
| Reconciled Cost Of Revenue |
|
5.66
-46.65%
|
10.61
-11.39%
|
11.97
-11.23%
|
13.48
|
| Gross Profit |
|
9.57
-55.49%
|
21.50
-48.18%
|
41.50
-18.19%
|
50.73
|
| Operating Expense |
|
39.73
-44.59%
|
71.70
-40.53%
|
120.58
+45.73%
|
82.74
|
| Research And Development |
|
7.57
-56.41%
|
17.37
-37.28%
|
27.69
+63.23%
|
16.97
|
| Selling General And Administration |
|
32.16
-40.81%
|
54.33
-41.50%
|
92.88
+41.22%
|
65.77
|
| Selling And Marketing Expense |
|
10.80
-58.34%
|
25.93
-44.66%
|
46.86
-7.04%
|
50.41
|
| General And Administrative Expense |
|
21.35
-24.81%
|
28.40
-38.30%
|
46.02
+199.54%
|
15.37
|
| Other Gand A |
|
21.35
-24.81%
|
28.40
-38.30%
|
46.02
+199.54%
|
15.37
|
| Total Expenses |
|
45.39
-44.86%
|
82.31
-37.90%
|
132.54
+37.75%
|
96.22
|
| Operating Income |
|
-30.16
+39.92%
|
-50.20
+36.52%
|
-79.08
-147.04%
|
-32.01
|
| Total Operating Income As Reported |
|
-30.16
+39.92%
|
-50.20
+36.52%
|
-79.08
-147.04%
|
-32.01
|
| EBITDA |
|
-27.70
-760.45%
|
-3.22
+95.48%
|
-71.24
-120.70%
|
-32.28
|
| Normalized EBITDA |
|
-31.81
-7.24%
|
-29.66
+64.15%
|
-82.73
-162.96%
|
-31.46
|
| Reconciled Depreciation |
|
0.98
-1.40%
|
1.00
+33.65%
|
0.75
-16.65%
|
0.90
|
| EBIT |
|
-28.68
-580.29%
|
-4.22
+94.14%
|
-71.99
-116.99%
|
-33.17
|
| Total Unusual Items |
|
4.11
-84.46%
|
26.44
+130.21%
|
11.48
+1498.90%
|
-0.82
|
| Total Unusual Items Excluding Goodwill |
|
4.11
-84.46%
|
26.44
+130.21%
|
11.48
+1498.90%
|
-0.82
|
| Special Income Charges |
|
0.40
-97.19%
|
14.19
+88.58%
|
7.52
|
0.00
|
| Other Special Charges |
|
0.66
-92.43%
|
8.71
-59.53%
|
21.53
|
—
|
| Restructuring And Mergern Acquisition |
|
-1.06
+95.38%
|
-22.90
+21.17%
|
-29.05
|
0.00
|
| Net Income |
|
-28.75
-299.49%
|
-7.20
+91.31%
|
-82.82
-119.42%
|
-37.74
|
| Pretax Income |
|
-28.68
-342.61%
|
-6.48
+92.15%
|
-82.55
-119.55%
|
-37.60
|
| Net Non Operating Interest Income Expense |
|
0.00
+100.00%
|
-2.26
+78.57%
|
-10.57
-138.73%
|
-4.43
|
| Interest Expense Non Operating |
|
0.00
-100.00%
|
2.26
-78.57%
|
10.57
+138.73%
|
4.43
|
| Net Interest Income |
|
0.00
+100.00%
|
-2.26
+78.57%
|
-10.57
-138.73%
|
-4.43
|
| Interest Expense |
|
0.00
-100.00%
|
2.26
-78.57%
|
10.57
+138.73%
|
4.43
|
| Other Income Expense |
|
1.48
-96.79%
|
45.98
+548.46%
|
7.09
+708.67%
|
-1.17
|
| Other Non Operating Income Expenses |
|
-2.63
-113.47%
|
19.54
+544.74%
|
-4.39
-1177.33%
|
-0.34
|
| Gain On Sale Of Security |
|
3.71
-69.72%
|
12.25
+209.26%
|
3.96
+582.58%
|
-0.82
|
| Tax Provision |
|
0.07
-89.69%
|
0.72
+171.97%
|
0.26
+84.62%
|
0.14
|
| Tax Rate For Calcs |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.86
-84.46%
|
5.55
+130.21%
|
2.41
+1498.90%
|
-0.17
|
| Net Income Including Noncontrolling Interests |
|
-28.75
-299.49%
|
-7.20
+91.31%
|
-82.82
-119.42%
|
-37.74
|
| Net Income From Continuing Operation Net Minority Interest |
|
-28.75
-299.49%
|
-7.20
+91.31%
|
-82.82
-119.42%
|
-37.74
|
| Net Income From Continuing And Discontinued Operation |
|
-28.75
-299.49%
|
-7.20
+91.31%
|
-82.82
-119.42%
|
-37.74
|
| Net Income Continuous Operations |
|
-28.75
-299.49%
|
-7.20
+91.31%
|
-82.82
-119.42%
|
-37.74
|
| Normalized Income |
|
-32.00
-13.94%
|
-28.09
+69.44%
|
-91.89
-147.71%
|
-37.10
|
| Net Income Common Stockholders |
|
-28.75
-299.49%
|
-7.20
+91.48%
|
-84.51
-107.90%
|
-40.65
|
| Diluted EPS |
|
-3.81
+67.27%
|
-11.64
+79.84%
|
-57.75
-164.25%
|
-21.85
|
| Basic EPS |
|
-3.81
+67.27%
|
-11.64
+79.84%
|
-57.75
-164.25%
|
-21.85
|
| Basic Average Shares |
|
7.54
+235.74%
|
2.25
+57.89%
|
1.42
-23.48%
|
1.86
|
| Diluted Average Shares |
|
7.54
+235.74%
|
2.25
+57.89%
|
1.42
-23.48%
|
1.86
|
| Diluted NI Availto Com Stockholders |
|
-28.75
-299.49%
|
-7.20
+91.48%
|
-84.51
-107.90%
|
-40.65
|
| Preferred Stock Dividends |
|
—
|
—
|
1.70
-41.62%
|
2.91
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
15.77
-51.93%
|
32.81
-54.24%
|
71.71
+39.60%
|
51.37
|
| Current Assets |
|
12.79
-52.89%
|
27.16
-58.10%
|
64.82
+49.40%
|
43.38
|
| Cash Cash Equivalents And Short Term Investments |
|
5.41
-64.81%
|
15.38
-59.57%
|
38.04
+394.95%
|
7.68
|
| Cash And Cash Equivalents |
|
5.41
-64.81%
|
15.38
-59.57%
|
38.04
+394.95%
|
7.68
|
| Receivables |
|
3.95
-44.62%
|
7.13
-60.79%
|
18.19
-38.00%
|
29.35
|
| Accounts Receivable |
|
3.95
-44.62%
|
7.13
-60.79%
|
18.19
-38.00%
|
29.35
|
| Gross Accounts Receivable |
|
9.11
-34.15%
|
13.84
-55.18%
|
30.86
+2.59%
|
30.09
|
| Allowance For Doubtful Accounts Receivable |
|
-5.16
+23.01%
|
-6.70
+47.12%
|
-12.67
-1609.99%
|
-0.74
|
| Inventory |
|
2.67
-21.47%
|
3.40
-44.90%
|
6.17
+59.66%
|
3.87
|
| Raw Materials |
|
1.23
+45.05%
|
0.85
-52.28%
|
1.78
+14.20%
|
1.56
|
| Work In Process |
|
0.79
+3.93%
|
0.76
-21.10%
|
0.97
+353.99%
|
0.21
|
| Finished Goods |
|
0.65
-63.83%
|
1.79
-47.80%
|
3.43
+63.50%
|
2.10
|
| Other Current Assets |
|
0.76
-38.94%
|
1.24
-48.51%
|
2.41
-2.94%
|
2.49
|
| Total Non Current Assets |
|
2.98
-47.32%
|
5.66
-17.97%
|
6.90
-13.66%
|
7.99
|
| Net PPE |
|
2.32
-49.05%
|
4.55
-28.84%
|
6.39
+21.02%
|
5.28
|
| Gross PPE |
|
6.66
-25.19%
|
8.90
-10.50%
|
9.95
+22.36%
|
8.13
|
| Accumulated Depreciation |
|
-4.34
+0.28%
|
-4.36
-22.42%
|
-3.56
-24.83%
|
-2.85
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
4.19
-13.92%
|
4.87
+28.06%
|
3.80
+34.44%
|
2.83
|
| Construction In Progress |
|
0.00
-100.00%
|
0.01
-98.83%
|
1.20
+104.97%
|
0.58
|
| Other Properties |
|
0.95
-54.30%
|
2.08
-30.93%
|
3.01
+3.83%
|
2.90
|
| Leases |
|
1.52
-21.72%
|
1.94
+0.00%
|
1.94
+6.64%
|
1.82
|
| Other Non Current Assets |
|
0.66
-40.22%
|
1.11
+119.60%
|
0.51
-81.34%
|
2.71
|
| Total Liabilities Net Minority Interest |
|
92.96
-16.09%
|
110.79
-22.53%
|
143.01
+70.89%
|
83.68
|
| Current Liabilities |
|
38.45
+103.81%
|
18.86
-71.17%
|
65.42
-13.76%
|
75.87
|
| Payables And Accrued Expenses |
|
8.73
-48.50%
|
16.95
-29.93%
|
24.19
+33.27%
|
18.15
|
| Payables |
|
3.57
-45.71%
|
6.57
-36.68%
|
10.38
+78.67%
|
5.81
|
| Accounts Payable |
|
3.57
-45.71%
|
6.57
-36.68%
|
10.38
+78.67%
|
5.81
|
| Current Accrued Expenses |
|
5.16
-50.26%
|
10.38
-24.86%
|
13.81
+11.90%
|
12.34
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
1.25
+19.31%
|
1.05
-38.00%
|
1.69
-51.14%
|
3.45
|
| Current Debt And Capital Lease Obligation |
|
28.47
+3175.95%
|
0.87
-97.80%
|
39.55
-27.12%
|
54.27
|
| Current Debt |
|
28.07
|
—
|
38.64
-27.58%
|
53.36
|
| Other Current Borrowings |
|
28.07
|
—
|
38.64
-27.58%
|
53.36
|
| Current Capital Lease Obligation |
|
0.40
-54.20%
|
0.87
-4.30%
|
0.91
+0.33%
|
0.91
|
| Current Deferred Liabilities |
|
—
|
—
|
—
|
0.00
|
| Current Deferred Revenue |
|
—
|
—
|
—
|
0.00
|
| Total Non Current Liabilities Net Minority Interest |
|
54.52
-40.70%
|
91.93
+18.49%
|
77.58
+892.50%
|
7.82
|
| Long Term Debt And Capital Lease Obligation |
|
0.57
-98.46%
|
37.05
+1506.85%
|
2.31
-56.21%
|
5.27
|
| Long Term Debt |
|
—
|
35.71
|
—
|
3.10
|
| Long Term Capital Lease Obligation |
|
0.57
-57.51%
|
1.34
-41.72%
|
2.31
+6.61%
|
2.16
|
| Other Non Current Liabilities |
|
48.12
-4.36%
|
50.31
-26.57%
|
68.51
+2585.73%
|
2.55
|
| Preferred Securities Outside Stock Equity |
|
—
|
—
|
—
|
39.12
|
| Stockholders Equity |
|
-77.19
+1.01%
|
-77.98
-9.37%
|
-71.30
-120.64%
|
-32.31
|
| Common Stock Equity |
|
-77.19
+1.01%
|
-77.98
-9.37%
|
-71.30
-120.64%
|
-32.31
|
| Capital Stock |
|
0.01
+100.00%
|
0.00
+50.00%
|
0.00
+100.00%
|
0.00
|
| Common Stock |
|
0.01
+100.00%
|
0.00
+50.00%
|
0.00
+100.00%
|
0.00
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
12.29
+353.41%
|
2.71
+42.10%
|
1.91
+2.55%
|
1.86
|
| Ordinary Shares Number |
|
12.29
+353.41%
|
2.71
+42.10%
|
1.91
+2.55%
|
1.86
|
| Additional Paid In Capital |
|
168.63
+10.51%
|
152.60
+6.70%
|
143.01
+43.19%
|
99.88
|
| Retained Earnings |
|
-250.96
-12.94%
|
-222.21
-3.35%
|
-215.01
-62.65%
|
-132.19
|
| Gains Losses Not Affecting Retained Earnings |
|
5.14
+161.41%
|
-8.37
-1295.71%
|
0.70
|
0.00
|
| Other Equity Adjustments |
|
5.14
+161.41%
|
-8.37
-1295.71%
|
0.70
|
—
|
| Total Equity Gross Minority Interest |
|
-77.19
+1.01%
|
-77.98
-9.37%
|
-71.30
-120.64%
|
-32.31
|
| Total Capitalization |
|
-77.19
-82.62%
|
-42.27
+40.72%
|
-71.30
-144.08%
|
-29.21
|
| Working Capital |
|
-25.65
-409.33%
|
8.29
+1461.74%
|
-0.61
+98.13%
|
-32.48
|
| Invested Capital |
|
-49.12
-16.21%
|
-42.27
-29.44%
|
-32.65
-235.22%
|
24.15
|
| Total Debt |
|
29.04
-23.43%
|
37.92
-9.40%
|
41.86
-29.69%
|
59.53
|
| Net Debt |
|
22.66
+11.45%
|
20.33
+3254.95%
|
0.61
-98.76%
|
48.78
|
| Capital Lease Obligations |
|
0.97
-56.21%
|
2.21
-31.14%
|
3.21
+4.76%
|
3.07
|
| Net Tangible Assets |
|
-77.19
+1.01%
|
-77.98
-9.37%
|
-71.30
-120.64%
|
-32.31
|
| Tangible Book Value |
|
-77.19
+1.01%
|
-77.98
-9.37%
|
-71.30
-120.64%
|
-32.31
|
| Derivative Product Liabilities |
|
5.83
+27.63%
|
4.57
-32.49%
|
6.76
|
0.00
|
| Interest Payable |
|
—
|
—
|
0.00
-100.00%
|
0.49
|
| Preferred Stock Equity |
|
—
|
—
|
—
|
58.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-28.95
+31.57%
|
-42.30
+33.89%
|
-63.98
-36.19%
|
-46.98
|
| Cash Flow From Continuing Operating Activities |
|
-28.95
+31.57%
|
-42.30
+33.89%
|
-63.98
-36.19%
|
-46.98
|
| Net Income From Continuing Operations |
|
-28.75
-299.49%
|
-7.20
+91.31%
|
-82.82
-119.42%
|
-37.74
|
| Depreciation Amortization Depletion |
|
0.98
-1.40%
|
1.00
+33.65%
|
0.75
-16.65%
|
0.90
|
| Depreciation |
|
0.98
-1.40%
|
1.00
+33.65%
|
0.75
-16.65%
|
0.90
|
| Depreciation And Amortization |
|
0.98
-1.40%
|
1.00
+33.65%
|
0.75
-16.65%
|
0.90
|
| Other Non Cash Items |
|
3.60
+109.64%
|
-37.40
-653.96%
|
-4.96
-341.18%
|
2.06
|
| Stock Based Compensation |
|
3.15
+2.95%
|
3.06
-63.43%
|
8.36
+1812.36%
|
0.44
|
| Provisionand Write Offof Assets |
|
4.06
+11.44%
|
3.65
-74.09%
|
14.07
+3127.98%
|
0.44
|
| Operating Gains Losses |
|
-10.84
-25.07%
|
-8.67
-200.52%
|
-2.88
-497.38%
|
0.73
|
| Gain Loss On Investment Securities |
|
-11.30
+37.15%
|
-17.98
-170.98%
|
-6.63
-890.70%
|
0.84
|
| Unrealized Gain Loss On Investment Securities |
|
9.09
+90.53%
|
4.77
+8.38%
|
4.40
|
0.00
|
| Net Foreign Currency Exchange Gain Loss |
|
-0.21
-134.68%
|
0.59
+430.00%
|
-0.18
-59.29%
|
-0.11
|
| Change In Working Capital |
|
-7.82
-589.00%
|
1.60
+724.74%
|
0.19
+101.41%
|
-13.79
|
| Change In Receivables |
|
0.84
-90.60%
|
8.98
+781.11%
|
-1.32
+94.22%
|
-22.82
|
| Changes In Account Receivables |
|
0.84
-90.60%
|
8.98
+781.11%
|
-1.32
+94.22%
|
-22.82
|
| Change In Inventory |
|
-0.49
-189.50%
|
0.54
+114.66%
|
-3.71
-222.17%
|
-1.15
|
| Change In Prepaid Assets |
|
0.80
-12.38%
|
0.91
+220.35%
|
0.28
+149.39%
|
-0.58
|
| Change In Payables And Accrued Expense |
|
-8.19
-2.36%
|
-8.00
-239.78%
|
5.72
-50.20%
|
11.49
|
| Change In Accrued Expense |
|
-5.04
-23.86%
|
-4.07
-485.34%
|
1.06
-87.05%
|
8.16
|
| Change In Payable |
|
-3.14
+19.95%
|
-3.92
-184.13%
|
4.66
+40.31%
|
3.32
|
| Change In Account Payable |
|
-3.14
+19.95%
|
-3.92
-184.13%
|
4.66
+40.31%
|
3.32
|
| Change In Other Current Liabilities |
|
-0.80
+4.78%
|
-0.84
-5.96%
|
-0.79
-7.64%
|
-0.73
|
| Investing Cash Flow |
|
0.00
+100.00%
|
-0.61
+61.96%
|
-1.61
-3.61%
|
-1.55
|
| Cash Flow From Continuing Investing Activities |
|
0.00
+100.00%
|
-0.61
+61.96%
|
-1.61
-3.61%
|
-1.55
|
| Net PPE Purchase And Sale |
|
0.00
+100.00%
|
-0.61
+61.96%
|
-1.61
-3.61%
|
-1.55
|
| Purchase Of PPE |
|
0.00
+100.00%
|
-0.61
+61.96%
|
-1.61
-3.61%
|
-1.55
|
| Capital Expenditure |
|
—
|
-0.61
+61.96%
|
-1.61
-3.61%
|
-1.55
|
| Financing Cash Flow |
|
18.97
-6.13%
|
20.21
-78.95%
|
95.99
+214.33%
|
30.54
|
| Cash Flow From Continuing Financing Activities |
|
18.97
-6.13%
|
20.21
-78.95%
|
95.99
+214.33%
|
30.54
|
| Net Issuance Payments Of Debt |
|
0.00
-100.00%
|
0.28
+294.37%
|
0.07
-99.77%
|
30.95
|
| Issuance Of Debt |
|
0.00
-100.00%
|
48.00
-45.75%
|
88.48
+185.85%
|
30.95
|
| Repayment Of Debt |
|
0.00
+100.00%
|
-47.72
+46.02%
|
-88.41
|
0.00
|
| Long Term Debt Issuance |
|
0.00
-100.00%
|
48.00
-45.75%
|
88.48
+185.85%
|
30.95
|
| Long Term Debt Payments |
|
0.00
+100.00%
|
-47.72
+46.02%
|
-88.41
|
0.00
|
| Net Long Term Debt Issuance |
|
0.00
-100.00%
|
0.28
+294.37%
|
0.07
-99.77%
|
30.95
|
| Net Common Stock Issuance |
|
18.97
-10.77%
|
21.26
|
0.00
|
—
|
| Proceeds From Stock Option Exercised |
|
0.00
-100.00%
|
0.03
-87.79%
|
0.21
+61.36%
|
0.13
|
| Net Other Financing Charges |
|
—
|
-1.36
-101.42%
|
95.70
+17563.87%
|
-0.55
|
| Changes In Cash |
|
-9.98
+56.06%
|
-22.70
-174.69%
|
30.40
+268.93%
|
-17.99
|
| Beginning Cash Position |
|
15.72
-59.09%
|
38.42
+378.89%
|
8.02
-69.16%
|
26.02
|
| End Cash Position |
|
5.74
-63.47%
|
15.72
-59.09%
|
38.42
+378.89%
|
8.02
|
| Free Cash Flow |
|
-28.95
+32.54%
|
-42.91
+34.57%
|
-65.59
-35.15%
|
-48.53
|
| Interest Paid Supplemental Data |
|
0.00
-100.00%
|
2.67
-66.75%
|
8.04
+131.16%
|
3.48
|
| Common Stock Issuance |
|
18.97
-10.77%
|
21.26
|
0.00
|
—
|
| Interest Paid CFO |
|
-2.41
+22.21%
|
-3.10
-183.70%
|
-1.09
|
0.00
|
| Issuance Of Capital Stock |
|
18.97
-10.77%
|
21.26
|
0.00
|
0.00
|
| Net Preferred Stock Issuance |
|
—
|
—
|
—
|
0.00
|
| Preferred Stock Issuance |
|
—
|
—
|
—
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 10-K2026-03-30 View
- 8-K2026-03-12 View
- 8-K2026-03-02 View
- 8-K2026-02-25 View
- 8-K2026-02-23 View
- 8-K2026-01-12 View
- 8-K2025-12-19 View
- 42025-12-05 View
- 10-Q2025-11-17 View
- 42025-11-13 View
- 8-K2025-11-12 View
- 42025-11-07 View
- 8-K2025-10-03 View
- 10-Q2025-08-19 View
- 8-K2025-08-14 View
- 8-K2025-08-13 View
- 8-K2025-08-07 View
- 42025-05-21 View
- 10-Q2025-05-15 View
- 8-K2025-05-14 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|